INNOVATE BIOPHARMACEUTICLS I's ticker is INNT and the CUSIP is 45782F105. A total of 48 filers reported holding INNOVATE BIOPHARMACEUTICLS I in Q3 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $16,000 | -5.9% | 14,692 | 0.0% | 0.00% | – |
| Q2 2019 | $17,000 | -85.7% | 14,692 | -76.2% | 0.00% | – |
| Q1 2019 | $119,000 | -24.7% | 61,719 | -10.1% | 0.00% | – |
| Q4 2018 | $158,000 | -42.3% | 68,676 | +71.6% | 0.00% | – |
| Q3 2018 | $274,000 | -70.1% | 40,028 | +2.9% | 0.00% | – |
| Q2 2018 | $917,000 | – | 38,918 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|